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Genipin crosslinked chitosan/PEO
nanofibrous scaffolds exhibiting an
improved microenvironment for the
regeneration of articular cartilage
Kuan Yong Ching1,2 , Orestis Andriotis3, Bram Sengers4 and
Martin Stolz2
Abstract
Towards optimizing the growth of extracellular matrix to produce repair cartilage for healing articular cartilage (AC)
defects in joints, scaffold-based tissue engineering approaches have recently become a focus of clinical research. Scaffold-
based approaches by electrospinning aim to support the differentiation of chondrocytes by providing an ultrastructure
similar to the fibrillar meshwork in native cartilage. In a first step, we demonstrate how the blending of chitosan with
poly(ethylene oxide) (PEO) allows concentrated chitosan solution to become electrospinnable. The chitosan-based
scaffolds share the chemical structure and characteristics of glycosaminoglycans, which are important structural com-
ponents of the cartilage extracellular matrix. Electrospinning produced nanofibrils of 100 nm thickness that are closely
mimicking the size of collagen fibrils in human AC. The polymer scaffolds were stabilized in physiological conditions and
their stiffness was tuned by introducing the biocompatible natural crosslinker genipin. We produced scaffolds that were
crosslinked with 1.0% genipin to obtain values of stiffness that were in between the stiffness of the superficial zone
human AC of 600 150 kPa and deep zone AC of 1854 483 kPa, whereas the stiffness of 1.5% genipin crosslinked
scaffold was similar to the stiffness of deep zone AC. The scaffolds were degradable, which was indicated by changes in
the fibril structure and a decrease in the scaffold stiffness after seven months. Histological and immunohistochemical
analysis after three weeks of culture with human articular chondrocytes (HACs) showed a cell viability of over 90% on
the scaffolds and new extracellular matrix deposited on the scaffolds.
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Introduction
Tissue engineering and regenerative medicine are con-
cerned with the replacement or regeneration of cells,
tissues, or organs to restore the normal biological func-
tion in the human body. Besides skin also articular
cartilage was one of the first tissues of interest in
tissue engineering because it only exhibits one single
cell type (chondrocyte) and is avascular (lacks blood
vessels), aneural (no neurons and nerves), and alym-
phatic (no lymphatic system). Due to its structural sim-
plicity, AC was predicted to be one of the first tissues to
be successfully regenerated but this was proven to be
incorrect.1 A major hurdle in the engineering of AC is
the de-differentiation of chondrocytes when exposed to
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a synthetic microenvironment, which often results in
the development of calcified or fibrous cartilage exhib-
iting inferior functional properties and limits the pro-
duction of functional cartilage.
The growth and remodeling of tissues are based on
an ongoing, bidirectional interaction between cells and
the extracellular matrix (ECM), in which the ECM
exerts mechanical force directly on the cell membrane
or indirectly putting force on the integrins. Both path-
ways are initiating cell-signaling cascades that produce
changes in gene expressions, whereas cellular changes,
in turn, affect the composition and structural arrange-
ment of the ECM.2,3 To regrow functional AC, it is,
therefore, important to provide the cells with their
appropriate microenvironment, including the ultra-
structure, stiffness and growth factors to control the
cell fate and direct tissue development. Cells have
been found to grow and maintain their function
within a structure similar to their native extracellular
matrix, but they lose their function when placed into a
structure different from their native extracellular
matrix.4 Hence, it is vital to provide the cells with a
microenvironment that mimics the native AC and
favours neo-cartilage growth.5
Chitosan is the primary structural polymer in
arthropod exoskeletons, shells of crustaceans, or the
cuticles of insects. It is a polysaccharide made of
amino sugars and is technically widely used because
of its biocompatibility.6–8 Chitosan is composed of ran-
domly distributed b-(1,4) linked D-glucosamine and
N-acetyl-glucosamine (shown in Figure 1(a)).
Interestingly, its chemical structure shares some char-
acteristics with the chondroitin sulfate in AC (see
Figure 1(b)), a type of sulfated glycosaminoglycans
composed of repeating disaccharide structures of
N-acetyl-galactosamine and glucuronic acids.
Chondroitin sulfate is an important structural compo-
nent of the cartilage ECM that modulates the chondro-
cytes morphology, differentiation, and function.
Chitosan contains free amino groups that will be pro-
tonated under acidic conditions (pH< 6) to produce a
positive charge, which allows for its ionic interactions
with the negatively charged chondroitin sulfate,9 chon-
drocytes,10,11 growth factors, and cytokines,12,13 and
hence, increases the biomimicry of chitosan in vivo
environment. However, one of the main characteristics
that limits the use of chitosan as scaffold materials
for tissue engineering is its rigid and brittle nature,
which makes it prone to rupture when loaded.
Therefore, the mechanical integrity of chitosan needs
to be improved for application as pre-engineered carti-
lage constructs.
The morphology and ductility of chitosan can be
improved by blending or copolymerizing with other
polymers, preferably uncharged polymers, which can
prevent strong interactions between components.14 A
blending approach is an easy and cost-effective method
of combining at least two polymers to achieve specific
properties, and the process allows rapid mixing of the
system without large energy consumption and the
potential to avoid unfavourable chemical reactions.15
The properties of the blends can be manipulated
according to their end use. A well-known uncharged
polymer that is widely used for blending with other
biopolymers is poly(ethylene oxide) (PEO). It is one
of the few synthetic polymers with the Food and
Drug Administration (FDA) approval 16 and proven
to be able to evoke cell proliferation and extracellular
matrix generation, both in vitro and in vivo.17–19 It
exhibits a structure of which each ethylene oxide unit
is capable of binding with two to three water mole-
cules.20 This creates a hydrophilic entrapment for the
hydrophobic chitosan,21 rendering the chitosan/PEO
blends highly hydrated, which is a feature needed for
the transportation of nutrients in AC. Based on the
intermolecular interactions between the various com-
ponents that are occurring mainly due to hydrogen
bonds and electrostatic interactions, chitosan/PEO
blends with tailored chemical and mechanical proper-
ties can be created. Furthermore, blending PEO with
chitosan will inevitably reduce the brittle nature of chi-
tosan. This is because PEO with ultra-high molecular
weight (>1 million Da) exists in flexible long chains



























Figure 1. Structure of (a) chitosan and (b) chondroitin sulfate, the primary glycosaminoglycan present in AC.
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polymer backbone, thus, allowing its application as a
structural support.14,22
Chitosan and PEO are both unstable and soluble in
physiological buffers and, therefore, crosslinking
agents are needed to bind the polymer network togeth-
er to prevent the individual kinetic chains from dissolv-
ing into the surrounding solution. Chemical
crosslinking agents react primarily with the amine
groups on amino acids or proteins. Various chemical
crosslinking agents, e.g., epoxy compounds, aldehydes,
and carbodiimides, have been developed to stabilize the
degradation of chitosan and tailor their mechanical
properties, with glutaraldehyde probably being the
most often used crosslinking agent in biomedical scien-
ces.23 However, these chemical reagents are cytotoxic
and may impair the biocompatibility of the crosslinked
biomaterials. For example, it has been reported that
even prolonged washing of 60minutes was insufficient
to remove the cytotoxic effects of glutaraldehyde due to
its slow leaching behaviour.24 Therefore, much interest
has been directed towards the naturally derived cross-
linking agent, i.e., genipin, which is a crosslinker iso-
lated from the Gardenia jasminoides Ellis fruit, and has
been used in traditional Chinese medicine. Genipin was
originally identified as a protein crosslinking agent,
which reacts with free amino groups through oxygen
radical-induced polymerization and dehydrogena-
tion.25,26 It has been investigated as a crosslinking
agent for biomaterials, e.g., chitosan,27–29 collagen,29
gelatin 27 and silk fibroin.28 The biocompatibility of
genipin has been proven to be better than synthetic
crosslinking agents such as glutaraldehyde, formalde-
hyde, and epoxy compounds.30,31 Indeed, genipin was
about five to ten thousand times less cytotoxic and
evoked 5000 times more cell proliferation than glutar-
aldehyde.32,33 It has also been shown that tissues and
scaffolds crosslinked by genipin exhibit improved ten-
sile strength and toughness, compared to glutaralde-
hyde and epoxy crosslinkers.32–34 Hence, genipin was
used as the crosslinking agent to reduce the solubility
of chitosan/PEO blends before they can serve as scaf-
fold materials in physiological conditions, and to
achieve the desired mechanical properties.
Since a microenvironment that mimics native carti-
lage is vital for the differentiation of chondrocytes, an
ultrastructure comparable to the fibrillar meshwork in
native cartilage can be obtained by electrospinning.
The blending of chitosan with PEO has an added
advantage, in this case as it allows the concentrated
chitosan solution to become electrospinnable as a
result of the enhanced chain entanglement due to the
formation of hydrogen bonding between amino hydro-
gen (-NH2) from chitosan and oxygen (-C-O-C-) from
PEO.35,36 The electrospun chitosan/PEO nanofibrous
scaffolds, which mimic the collagen fibril meshwork
of collagen, may serve as temporary cell matrices to
transmit the tensile loads, whereas the glucosamine
chemistry of chitosan could support the compressive
stresses, mimicking the roles of fibrous collagen and
glycosaminoglycan in the natural extracellular
matrix.37 We hope to be able to tune the structural
and mechanical properties of chitosan by combining
it with the correct proportion of PEO and genipin
crosslinker, thus, allowing it to serve as a structural
support for the attachment of chondrocytes and lead
to the generation of functional cartilage.
Materials and methods
Fabrication of chitosan/PEO nanofibrous scaffolds
Chitosan from crab shells with degree of deacetylation
>85% and molecular weight of 190,000–310,000Da
(middle viscous, 28191; Sigma-Aldrich, Gillingham,
UK) and PEO with molecular weight >5MDa
(A15536; Alfa Aesar, Lancaster, UK) were blended at
a weight ratio of 1:0.33 and dissolved in aqueous sol-
vent of 3.0% (w/w) acetic acid (33209; Sigma-Aldrich).
Co-solvents containing 10% (w/w) of dimethyl sulfox-
ide (DMSO, D4540; Sigma-Aldrich) and 0.3% (w/w) of
Triton X-100 (437002A; VWR International, Poole,
UK) were added to improve the electrospinning condi-
tion. The blend solutions were stirred at room temper-
ature for 24 hours until viscous transparent solutions
were obtained. Electrospinning was employed using a
solution flow rate of 2ll/min. Voltage supply and dis-
tance between the spinneret and collector were adjusted
until a stable jet was obtained.
The electrospun chitosan/PEO scaffolds were then
immersed in genipin solution for crosslinking reaction
to occur. To prepare genipin solution, genipin powder
(98%; Challenge Bioproducts, Yun-Lin Hsien, Taiwan)
was dissolved in aqueous solution of 90% ethanol to
obtain concentrations of 0.5%, 0.8%, 1.0% and 1.5%
(w/w). A minimum concentration of 0.5% was used as
a requirement to ensure complete crosslinking.38 The
completion of crosslinking reaction was indicated by a
colour change of the scaffolds from white to greenish
blue, which occurred after a period of approximately
14 days. The crosslinked scaffolds were rinsed with
excess of deionised water and immersed in water over-
night to eradicate excess or unreacted genipin.
Preparation of human articular cartilage
Human AC sample was obtained from the femoral
head of haematologically normal osteoarthritic patient
(age: 80 years) undergone total hip replacement surgery
at the Southampton General Hospital, with the
approval of the Southampton General Hospital and
l. 3
506 Journal of Biomaterials Applications 36(3)
South West Hants Local research Ethnics Committee
(LREC 194/99/1 and 210/01). Cartilage samples were
taken from areas with no apparent signs of damage or
disease and stored in minimum essential medium alpha
(a-MEM, 11900–073; Life Technologies, Paisley, UK)
on ice or at 4 �C until use.
Scanning electron microscopy
The structure of scaffolds and human AC was investi-
gated by scanning electron microscopy (SEM, JSM-
6500F; JEOL, Tokyo, Japan) after enzymatic depletion
of the proteoglycan moiety and chondrocytes in
phosphate-buffered solutions (PBS, H15–002; PAA
Laboratories, Pasching, Austria) containing 1mg/ml
bovine hyaluronidase (type I, H3506; Sigma-Aldrich)
and 1mg/ml trypsin (Trypsin-EDTA, T4174; Sigma-
Aldrich) at 37 �C for three days. Specimens were then
fixed with 4% paraformaldehyde (P/0840/53; Fisher
Scientific, Loughborough, UK) in PBS for 4 hours at
room temperature, rinsed with water and dehydrated in
graded ethanol series.
Prior to SEM imaging, all chitosan/PEO scaffolds
and cartilage samples were coated with a thin conduct-
ing layer of gold (�10 nm) with a Hummer 6.2 Sputter
System (Anatech, Union City, CA). Images were
obtained using an emission current of 10 mA and an
accelerating voltage of 10 kV.
Indentation-type atomic force microscopy
A micrometre-sized spherical indenter made of borosil-
icate glass (radius, r¼ 5mm, 02715-AB; SPI Supplies,
West Chester, PA) was used to measure the overall
stiffness properties of the various structural elements
composing AC, as well as the overall stiffness contrib-
uted by the electrospun fibril meshwork. The spherical
probe was glued onto tipless rectangular cantilever
(spring constant, kc �6N/m, type All In One-TL;
BudgetSensors, Sofia, Bulgaria). Measurements by
indentation-type atomic force microscopy (IT-AFM;
MFP-3D; Asylum Research, Santa Barbara, CA)
were carried out in PBS solution following protocols
developed by our group.39–41 A maximum deflection of
100 nm was employed, corresponding to a load of �600
nN. Cyclic load-displacement curves were recorded at
0.5Hz. Each individual data set consisted of 1024 load-
displacement curves in a 32� 32 curve grid, covering a
sample area of 30� 30 mm, at three different locations.
The indentation depths were less than 10% of the over-
all sample thickness. The stiffness of sample, E, was
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where v is the Poisson’s ratio of the sample, S is the
contact stiffness with the dimension of force per unit
depth, A is the projected contact area.
Degradation of chitosan/PEO nanofibrous scaffolds
The degradation of scaffolds was tested in a-MEM
medium at 37 �C. The medium was changed every
2 days. The structure and stiffness of the scaffolds
was examined by SEM and IT-AFM, respectively,
after one and seven months of degradation.
Biocompatibility of chitosan/PEO nanofibrous
scaffolds
The biocompatibility of scaffolds was tested with
HACs, which were isolated from the cartilage speci-
mens following digestion in trypsin-EDTA for
30minutes, 1mg/ml hyaluronidase for 15minutes and
10mg/ml collagenase B (11088831001; Roche
Diagnostics, West Sussex, UK) for 15 hours. The
isolated HACs were then expanded in a-MEM
supplemented with 10% fetal bovine serum (FBS,
10270–106; Life Technologies), 100 unit/ml penicillin,
100 lg/ml streptomycin (Penicillin-Streptomycin,
P4333; Sigma-Aldrich) and 100 lM L-ascorbic acid
2-phosphate sequimagnesium salt hydrate (A8960;
Sigma-Aldrich). The HACs were harvested at conflu-
ence by trypsinization after one passage. Scaffolds were
sterilised with absolute ethanol, rinsed with PBS, and
seeded with HACs at a density of �7� 105 cells/cm2.
The HACs-seeded scaffolds were cultured in chondro-
genic induction medium made up of a-MEM supple-
mented with 10 ng/ml recombinant human
transforming growth factor-b3 (TGF-b3, 100-36E;
Peprotech, London, UK), 100 lM L-ascorbic acid
2-phosphate sequimagnesium salt hydrate, 10 nM
dexamethasone (D4902; Sigma-Aldrich), and Insulin-
Transferrin-Selenium-G (ITS-G, 41400; Life
Technologies). All tissue cultures were incubated at
37 �C in humidified atmosphere with 5% CO2. Media
were exchanged every two days. The constructs were
harvested for live/dead cell staining, histological and
immunohistochemical analysis after three weeks.
Live/dead cell staining. Metabolically active and necrotic
cells were labelled with 10 mg/ml Cell Tracker Green
CMFDA (5-chloromethylfluorescein diacetate, C7025;
Life Technologies) and 5mg/ml Ethidium Homodimer-
1 (E1169; Life Technologies), respectively, for an hour.
The constructs were incubated in tissue culture medium
4 Journal of Biomaterials A plications 0 0
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for 45minutes and then fixed with 4% paraformalde-
hyde in PBS. The specimens were embedded in paraffin
wax and sequential sections were cut in sections of
7 lm. After de-waxing with Histoclear (HS200;
National Diagnostics, Leicestershire, UK) and re-
hydration through graded ethanol, cell nuclei were
stained with DAPI (4’,6-diamidino-2-phenylindole,
dilactate, D3571; Life Technologies). Fluorescent
images were acquired with Axiovert 200 microscope
(Carl Zeiss Microscopy, Jena, Germany) equipped
with Zeiss AxioCam HR colour camera, AxioCam
MR3 monochrome camera and the Zeiss AxioVision
4.6 software.
Histology and immunohistochemistry. After de-waxing with
Histoclear and re-hydrating through graded ethanol,
cell nuclei were counter-stained with haematoxylin
(H/0010/46; Fisher Scientific). The proteoglycan con-
tent was stained with 5mg/ml Alcian blue 8GX (40046–
0100; Acros Organics, Geel, Belgium) while total col-
lagen content was stained with 10mg/ml Direct Red 80
(365548; Sigma-Aldrich).
The expression of SOX-9, aggrecan, collagen I, II
and X in the neo-cartilage were detected by immuno-
histochemistry. For anti-SOX-9 and anti-aggrecan
antibodies, sections were treated with heat-induced
antigen retrieval in 0.01M citrate buffer at 60C for
25minutes, followed by quenching endogeneous perox-
idase with 3% hydrogen peroxide (H2O2) and blocking
with 1% bovine serum albumin (A3294, Sigma-
Aldrich) in PBS. For anti-collagen I, II and X antibod-
ies, sections were quenched with 3% H2O2, incubated
with 520 lg/ml bovine hyaluronidase at 37 C for
20minutes and then blocked with 1% bovine serum
albumin. Next, sections were incubated with the rele-
vant primary antibody at 4 C for 18 hours. The anti-
SOX-9 (AB5535; Millipore, Billerica, MA) and
anti-aggrecan (ab36861; Abcam, Cambridge, UK) anti-
bodies were used at dilution of 1:150, anti-collagen I
antibody (gift from Larry W. Fisher, National
Institutes of Health, Maryland) at 1:1000, anti-
collagen II (ab34712; Abcam) and anti-collagen X
(234196; Millipore) antibodies at 1:100. This was fol-
lowed by incubation with biotinylated secondary anti-
body (B7389; Sigma-Aldrich) at a dilution of 1:100 for
an hour. Visualization of the immune complex involved
the avidin-biotin method linked to peroxidase
(ExtrAvidin Peroxidase, E2886; Sigma-Aldrich) at a
dilution of 1:50 and 3-amino-9-ethylcarbazole (AEC,
132–32-1; Acros Organics, New Jersey). The reaction
products were reddish brown in colour. Negative con-
trols (omission of the primary antibody) were included
in the control sections. Images were captured using an
inverted light microscope (type BX51, Olympus
Corporation, Tokyo, Japan) equipped with a dotSlide
virtual slide system.
Results
Structure of chitosan/PEO nanofibrous scaffolds
Chitosan/PEO blended at a ratio of 1:0.33 was electro-
spun into randomly oriented fibrils that are similar to
the collagen fibril meshwork in native AC. Figure 2(a)
shows the collagen fibril meshwork in human AC,
whereas Figure 2(b) shows electrospun chitosan/PEO
fibrils, which were defect-free with smooth surface
morphologies. The fibrils exhibited a uniform geometry
and clear boundaries between the fibrils. The average
fibril diameter estimated from approximately 50 fibrils
was 99 23 nm, twofold larger than the collagen fibrils
in cartilage.
The as-spun chitosan-PEO fibrils were stable in dry
state, but they rapidly dissolved when transferred to an
aqueous solution. Therefore, crosslinking was required
to improve the water resistance of chitosan/PEO scaf-
folds. After electrospinning, the chitosan/PEO scaffolds
were crosslinked with different concentrations of genipin
solutions, ranging from 0.5%, 0.8%, 1.0% to 1.5%.
This yielded scaffolds which remained undissolved
Figure 2. SEM micrographs comparing collagen fibril meshwork with electrospun fibril meshwork. (a) The collagen fibril meshwork
of human AC after proteoglycan extraction consists of a pseudo-random meshwork of smooth collagen fibrils. (b) The fine and
straight electrospun chitosan/PEO (1:0.33) fibrils with smooth surfaces. Scale bars: 500 nm.
l. 5
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upon contact with aqueous solution, indicating that
crosslinking conferred water resistance to the chitosan/
PEO fibrils. Figure 3 shows the structure of the cross-
linked fibrils, with some of the adjacent fibrils fused
together. All the crosslinked fibrils were swollen after
crosslinking, indicated by an increased fibril size, and
there was a higher degree of swelling when lower con-
centration of genipin was used. Before crosslinking, the
average diameter of the as-spun chitosan/PEO fibrils
was 99 23nm. The average fibril diameter increased
by 43% after crosslinking with 0.5% genipin, 21%
with 0.8% genipin, 4% with 1.0% genipin and 8%
with 1.5% genipin, shown in Figure 4.
Stiffness of chitosan/PEO nanofibrous scaffolds
Using spherical indenters with a radius of 5lm, the
overall stiffness of the various structural elements
Figure 3. SEM micrographs comparing electrospun chitosan/PEO fibrils crosslinked with different concentrations of genipin: (a)
0.5%, (b) 0.8%, (c) 1.0%, and (d) 1.5% genipin. Adjacent fibrils were fused together, forming bundle of fibrils. Crosslinks between some
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Figure 4. Average diameters of electrospun chitosan/PEO fibrils without crosslinking, and after crosslinking with various concen-
trations of genipin, in comparison with the diameter of collagen fibrils in human AC.
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composing AC and the stiffness properties of electro-
spun fibril meshwork were measured with IT-AFM.
The stiffness of superficial zone AC was measured on
the original cartilage surface, whereas deep zone AC
was measured after removing the superficial and
middle zones (2mm) of the sample. Load-
displacement curves were recorded using IT-AFM
and the unloading part of the curves are depicted in
Figure 5. Using data from the upper 25% of the
unloading curves, the stiffness was calculated with
Equation (1). As shown in Figure 6, the stiffness of
chitosan/PEO scaffolds increased with the increasing
concentration of the genipin crosslinker. Scaffold
crosslinked with 1.5% genipin exhibited the highest
stiffness, 1875 532 kPa, which is similar to the stiff-
ness of deep zone human AC of 1854 483 kPa. The
stiffness of 1.0% genipin crosslinked scaffold was
890 311 kPa, in between the stiffness of the deep
zone and superficial zone human AC of 600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Figure 5. The unloading part of the load-displacement curves measured on chitosan/PEO scaffolds crosslinked with different
concentrations of genipin crosslinker, in comparison with that measured on the superficial zone and deep zone human AC.
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Figure 6. Stiffness of the chitosan/PEO scaffolds in comparison with the stiffness of superficial zone and deep zone human AC. The
stiffness of scaffolds increases with the increasing concentration of the genipin crosslinker. The area in light grey shows the stiffness
measured on the superficial zone human AC (600 150 kPa), whereas the area in dark grey shows the stiffness measured on the deep
zone human AC (1854 483 kPa).
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stiffness of 719 240 kPa, which is similar to the super-
ficial zone human AC, while the stiffness of 0.5%
crosslinked scaffold was the lowest, recorded at
137 47 kPa.
Degradation of chitosan/PEO nanofibrous scaffolds
The column of Figure 7(a) to (d) shows the uniform
fibril morphology before degradation and changes of
the morphology after one month (Figure 7(e) to (h))
and seven months of degradation (Figure 7(i) to (l)).
The rows show the electrospun scaffolds crosslinked
with increasing concentration of genipin. Signs of deg-
radation were observed on the scaffolds crosslinked
with 0.5%, 0.8% and 1.0% genipin. At one month,
some adjacent fibrils were fused together. At seven
months, some of the fused fibrils had started to dissolve
and lost their fibrillar structure. A reduction in mesh
size was also visible, which may reduce the overall scaf-
fold volume. As shown in Figure 7(h) and (l), the struc-
ture of the 1.5% genipin-crosslinked scaffold remained
stable without the signs of degradation.
The stiffness of chitosan/PEO scaffolds crosslinked
with 0.5%, 0.8% and 1.0% genipin were reduced
because of scaffold degradation, as shown in
Figure 8. A large reduction of stiffness was observed
as early as one month, with 15% reduction on scaffold
crosslinked with 0.5% genipin, 57% reduction on that
with 0.8% genipin and 64% reduction on that with
1.0% genipin. At seven months, the stiffness of scaf-
folds crosslinked with 0.5%, 0.8% and 1.0% further
reduced to approximately 100 kPa, although their ini-
tial stiffness varied. In comparison, the scaffold cross-
linked with 1.5% genipin maintained its stiffness
throughout the course of the degradation period,
with a remaining stiffness of 1865 708 kPa after
seven months. This finding is in agreement with the
non-changing scaffold structure shown in Figure 7(h)
and (l).
Biocompatibility of chitosan/PEO nanofibrous
scaffolds
Figure 9 shows the fluorescence images of live and dead
HACs on genipin crosslinked chitosan/PEO scaffolds.
The scaffold fibrils are auto fluorescent, shown by the
large area of red fluorochromes that did not exhibit the
typical shapes of HACs. This finding has also been
Genipin





Figure 7. Comparison of SEM micrographs of chitosan/PEO scaffolds before and after hydrolytic degradation. (a-d) The original fibril
structure. (e-g) After one month of hydrolytic degradation, some adjacent fibrils were fused together, but (h) the structure of scaffold
crosslinked with 1.5% genipin remained unchanged. (i-k) After seven months, the fibrils further dissolved with a loss of fibril structure,
but (l) the structure of scaffold crosslinked with 1.5% genipin still remained unchanged. Scale bars: 500 nm.
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confirmed by simultaneously DAPI staining cell nuclei
and Cell Tracker Green stained cell cytoplasm. We
counted the number of live (green) and dead cells
(red) on the confocal images at three different locations
on a sample, and obtained a cell viability on the scaf-
folds of over 90%, with approximately 10% of necrotic
cells shown by the red fluorochromes. Only cells locat-
ed outside the auto-fluorescent area were counted to
avoid ambiguous red-fluorescent signals. All chitosan/
PEO scaffolds demonstrated a similar high degree of
cell viability, regardless of the concentration of genipin
crosslinker.
The biosynthesis and accumulation of extracellular
matrix on chitosan/PEO scaffolds crosslinked with
1.0% and 1.5% genipin are shown in Figures 10 and
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Figure 8. Decrease in the stiffness of chitosan/PEO scaffolds after hydrolytic degradation. The original stiffness of the scaffolds
crosslinked with four different genipin concentrations is indicated by “”. The stiffness of scaffolds after one month of degradation is
indicated by “”, whereas the stiffness after seven months of degradation is indicated by “”.
Figure 9. Viability test of HACs seeded on the chitosan/PEO scaffolds. The detected metabolically active cells (green fluorescence)
and necrotic cells (red fluorescence, arrow heads) on chitosan/PEO scaffolds crosslinked with (a) 0.5%, (b) 0.8%, (c) 1.0% and (d) 1.5%
genipin. The scaffold structure (denoted with “S”) was auto fluorescent. The images were taken in a single exposure through FITC
long-pass filter appropriate for fluorescein. Scale bars: 50lm.
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scaffolds are shown by the dark green colour, which
surrounds the reddish brown HACs. The inner struc-
ture of the scaffolds, however, was not filled with cells
(haematoxylin stained) or newly formed extracellular
matrix after three weeks. The cells were agglomerated
on the surface of the scaffolds and did not penetrate the
voids between fibrils. Moreover, histological staining
of proteoglycan (Alcian blue stained) and total colla-
gen (Sirius red stained) contents were mainly observed
among the cell agglomerates outside the scaffold struc-
ture (Figures 10(a) and 11(a)). By visible inspection in
the light microscope, the intensity of the histological
staining of both proteoglycan and total collagen con-
tent in the scaffold crosslinked with 1.0% genipin
(Figure 10(a)) was higher than that in the scaffold
crosslinked with 1.5% genipin (Figure 11(a)), which
indicates a higher amount of extracellular matrix in
the 1.0% genipin crosslinked scaffold.
A considerable amount of the chondrogenic differ-
entiation marker, SOX-9, was also detected in the cell
agglomerates on both constructs (Figures 10(b) and 11
(b)). The expression level of the cartilage specific pro-
teoglycan, the aggrecan, was higher on the 1.0% geni-
pin crosslinked scaffold shown in Figure 10(c)
compared to the 1.5% genipin crosslinked scaffold
shown in Figure 11(c). Our finding agrees with our
histological analysis, which showed a more intense pro-
teoglycan content on the 1.0% genipin crosslinked
scaffold. As shown in Figures 10(d) and 11(d), the
expression level of type II collagen on both constructs
was lower compared to the expression level of type I
collagen shown in Figures 10(e) and 11(e). This indi-
cates a fibrous characteristic of the repair tissue. Based
on Figures 10(f) and 11(f), the presence of type X col-
lagen is negligible on both constructs.
Discussion
Structure of chitosan/PEO nanofibrous scaffolds
The addition of non-ionogenic and flexible super-long-
chain PEO macromolecules plays a crucial part in
enhancing the chain entanglements to form stable
solid fibrils. Molecular interactions between chitosan
and PEO are formed by hydrogen bonds between the
amino groups in chitosan and the ether groups in PEO.
These bonds disrupt the self-association among chito-
san chains caused by the strong hydrogen bonding
between their NH2 and OH groups, which generally
result in a highly viscous chitosan solution. When
increasing the amount of PEO, the overall viscosity
of the polymer solution is decreased monotonically,
which allows the formation of a miscible polymer
blend system,36 and hence, stretches the polymer fibrils
efficiently during the electrospinning process to pro-
duce continuous and bead-free fibrils. We also added
co-solvents, such as DMSO and Triton X-100, into the
solution to improve the electrospinning conditions and
increase the fibril yield. DMSO relaxes chain entangle-
ment of chitosan, this results in higher structural uni-
formity in fibrils.35 Trace amounts of Triton X-100
(0.3%) act as a non-ionic surfactant so that an
Figure 10. Extracellular matrix formation on HACs-seeded chitosan/PEO scaffold crosslinked with 1.0% genipin. (a) Histology of
proteoglycan matrix is shown in blue and the total collagen matrix in red. Cell nuclei are shown in black, with an enlarged image
shown in inset. Areas marked with “S” are scaffold structure, of which cell nuclei are not observed. Immunohistochemistry of (b)
SOX-9, (c) aggrecan, (d) type II collagen, (e) type I collagen, (f) type X collagen with positive reaction detected with the chromogenic
AEC substrate and shown in reddish brown colour. Extracellular matrix was absent within the scaffold structure (dark green). Scale
bars: 50 mm.
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improved fibrous structure could be obtained at a high
chitosan-to-PEO ratio, which is desirable for cartilage
tissue engineering applications.
To increase the stability of chitosan/PEO scaffolds
in physiological conditions, genipin was used as the
crosslinking agent because it exhibits lower cytotoxicity
compared to other synthetic crosslinking agents and
may also provide high crosslinking efficiency. During
the crosslinking reaction, a covalent bond is formed
between the nitrogen from the amino group of chitosan
and the carbon from the carbonyl group of genipin. As
a result, there is an interconnected network that can
restrain chain slippage and increase the stiffness and
stability of the scaffolds.42 After crosslinking, some of
the fibrils were fused to form bundles of fibres, as
shown in Figure 3. All scaffolds showed an increased
fibril diameter after crosslinking. When a lower genipin
concentration was used, a higher degree of swelling was
observed (Figure 3). This is attributed to the higher
proportion of water in the genipin solution of lower
concentration.31 As a result of swelling, the pore size
of the scaffolds reduced, which, in turn reduced cell
penetration into the scaffold.
Stiffness of chitosan/PEO nanofibrous scaffolds
The genipin crosslinker is effective in regulating the
mechanical properties of scaffolds. By using a range
of genipin concentrations to crosslink chitosan/PEO,
scaffolds of the same chemistry but with a range of
crosslinking degrees were produced. A higher
concentration of genipin solution resulted into higher
crosslinking between fibrils and an increase of scaffold
stiffness as shown in Figure 6. However, the increase of
stiffness only works up to a threshold concentration,
beyond which there will be an increase in the fibril size
and crosslinking reaction that is limited at the scaffolds
surface, and results in a reduction of stiffness.29
Furthermore, it is important to obtain a balance
between maintaining high water content for cell viabil-
ity and exhibiting adequate mechanical integrity to
restore the function. Therefore, we chose the highest
genipin concentration of 1.5% for crosslinking the chi-
tosan/PEO in this study. In general, the stiffness of
chitosan/PEO nanofibrous scaffolds in this study
(890 kPa for scaffold crosslinked with 1.0% genipin)
is lower compared to the chitosan/PEO cast films
(2000 kPa for film crosslinked with 1.0% genipin)
reported in the literature.11,43 Such a variation is not
unexpected, since there are distinct differences in the
structure in both cases. Nonetheless, scaffolds cross-
linked both with 1.0% and 1.5% genipin exhibited
stiffness values comparable to the native cartilage.
Degradation of chitosan/PEO nanofibrous scaffolds
Although crosslinking with genipin yields interatomic
and intermolecular bonding, the physical and chemical
structure of the crosslinked scaffolds is still susceptible
to hydrolytic degradation.44 Indeed, chitosan with
deacetylation >85% has been reported to exhibit a deg-
radation rate of several months in vivo, which is
Figure 11. Extracellular matrix formation on HACs-seeded chitosan/PEO scaffold crosslinked with 1.5% genipin. (a) Histology of
proteoglycan matrix is shown in blue and the total collagen matrix in red. Cell nuclei are shown in black, with an enlarged image
shown in inset. Areas marked with “S” are scaffold structure, of which cell nuclei are not observed. Immunohistochemistry of (b)
SOX-9, (c) aggrecan, (d) type II collagen, (e) type I collagen, (f) type X collagen, with positive reaction detected with the chromogenic
AEC substrate and shown in reddish brown colour. Extracellular matrix was absent within the scaffold structure (dark green). Scale
bars: 50mm.
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considered suitable for cartilage repair purposes.12,45
The degradation rate of genipin crosslinked scaffolds
is inversely related to the genipin concentration 34,46 as
the introduction of more crosslinker molecules into the
polymer backbone hinders the attack of water mole-
cules. Under the effect of a-MEM medium at 37C,
chitosan/PEO crosslinked with 0.5%, 0.8% and 1.0%
genipin exhibited a loss of structural integrity, e.g.,
fibrils appeared swollen and dissolved, thus forming a
reduced mesh size of the scaffolds (Figure 7) as the
crosslinking of chitosan/PEO might be incomplete for
lower genipin concentrations. In comparison, the scaf-
fold crosslinked with 1.5% genipin retained its struc-
tural integrity. This complies well with the stiffness
measurements of the scaffolds, in which the stiffness
of the scaffolds with degraded structures reduced,
while the scaffold with an unchanged structure did
not show lower stiffness. Scaffolds with a higher
degree of crosslinking were more stable.
Biocompatibility of chitosan/PEO nanofibrous
scaffolds
A porous structure with interconnected pores is essen-
tial in the design of scaffolds towards AC repair to
provide the necessary space for cell adhesion and
matrix growth. Electrospinning of chitosan/PEO pro-
duced nanofibrous scaffolds that exhibited a porous
network, but the high density of the nanometre-sized
electrospun fibrils resulted in a denser packing of fibrils
and smaller mesh size compared to the meshwork
found in AC. The smaller mesh size prevents the cells
from penetrating the voids between the fibrils, and
depositing new extracellular matrix within the scaf-
folds. Consequently, extracellular matrix formation
was mainly observed at the surface of the scaffolds.
In addition, an increasing crosslinking density had
caused the fibrils to become brittle, which further lim-
ited subsurface migration of cells, and hence, cell pro-
liferation and proteoglycan synthesis.34,46,47 Figures 10
(a) and 11(a) show that the extracellular matrix forma-
tion on the 1.0% genipin crosslinked scaffold was
higher than that on the 1.5% genipin crosslinked scaf-
fold, which may be a direct consequence of the differ-
ences in the scaffolds’ mesh sizes. A smaller mesh size
of the higher crosslinked scaffold (1.5%) also results in
a slower diffusion of physiological nutrients and may
reduce cell proliferation and physically lower cell
expansion. Previous research also reported that chon-
drocytes within PEG hydrogels of higher crosslinking
density exhibited decreased cell proliferation, which
was associated with a lower total DNA content.47 In
the higher crosslinked and stiffer gels, the chondrocytes
were less metabolically active and sterically impeded
from the increase in cell diameter.48 In addition, the
non-degradable behaviour of the 1.5% genipin cross-
linked scaffold also obstructs the ingrowth of the extra-
cellular matrix.
Our analysis of extracellular matrix formation,
which unfortunately was fibrous-like, exhibiting a
higher content of type I collagen rather than the for-
mation of type II collagen. The newly formed tissue on
the scaffold crosslinked with 1.5% geninpin looked
more fibrous-like compared to that crosslinked with
1.0% genipin, suggesting that a higher crosslinking
density exerts an effect on the de-differentiation of
chondrocytes.
Conclusion
Electrospinning of chitosan/PEO followed by cross-
linking with genipin produced nanofibrous scaffolds
that closely mimic the structure and stiffness of the
collagen fibril meshwork in native AC. When increas-
ing the concentration of genipin, we observed smaller
fibril diameters and an increase in the stiffness of the
scaffolds. Crosslinking the chitosan/PEO scaffold with
0.8% and 1.0% genipin resulted in a stiffness of the
polymer meshwork similar to the superficial zone of
human AC of 600 150 kPa, whereas the stiffness of
scaffold crosslinked with 1.5% genipin was comparable
to the stiffness of deep zone cartilage of 1854
483 kPa. Following our biocompatibility assays, we
did not observe significant signs of degradation, even
after seven months, in the scaffold crosslinked with
1.5% genipin. However, we observed degradation of
structure and stiffness when the concentration of gen-
ipin crosslinker was lower than 1.0%. Due to the high
fibril density of the nanometre-sized fibrils, the scaf-
folds exhibited mesh sizes that were relatively smaller
than the size of HACs so the extracellular matrix for-
mation was mainly concentrated on the scaffold sur-
face. We conclude that chitosan/PEO scaffolds
crosslinked with approximately 1.0% genipin were
appropriate for cell proliferation and tissue regenera-
tion. As an improvement of the electrospinning
method, we proposed wet electrospinning, which
allows electrospun fibrils to deposit in an aqueous solu-
tion, to solve the problem with the overly dense fine
fibrils as it will allow more equal cell seeding and pro-
liferation. Taken together, this work is a step further
towards tailoring the structure and stiffness of scaffolds
to produce engineered cartilage for healing cartilage
defects in patients and to avoid secondary osteoarthri-
tis and joint replacement surgery.
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